« Back to Record
Citation APA

Heldmann, F., de Vlam, K., Gaston, H., Gruenke, M., Witt, M., Appelboom, T., Emery, P., Dougados, M., Leirisalo-Repo, M., Bréban, M., Braun, J., Baraliakos, X., Kiltz, U., Brandt, J., van der Horst-Bruinsma, I. I., Landewe, R., Sieper, J., Burmester, G. R., & Van Den Bosch, F. (2016). Clinical experience with the European ankylosing spondylitis infliximab cohort (EASIC): Long-term extension over 7 years with focus on clinical efficacy and safety. Clinical and Experimental Rheumatology, 34(2), 184-190.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231481

Heldmann, F., de Vlam, K., Gaston, H., Gruenke, M., Witt, M., Appelboom, T., Emery, P., Dougados, M., Leirisalo-Repo, M., Bréban, M., Braun, J., Baraliakos, X., Kiltz, U., Brandt, J., van der Horst-Bruinsma, I. I., Landewe, R., Sieper, J., Burmester, G. R., & Van Den Bosch, F. (2016). Clinical experience with the European ankylosing spondylitis infliximab cohort (EASIC): Long-term extension over 7 years with focus on clinical efficacy and safety. Clinical and Experimental Rheumatology, 34(2), 184-190.